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Abstract 
The asymmetric synthesis of the (6R)-hydroxymethyl-5,6-dihydro-2H-pyran-2-one, a key 
intermediate in the formal synthesis of (R)-argentilactone, and the total synthesis of (R)-
goniothalamin are described. Our aproach involved the Lemieux-Johnson oxidative cleavage, 
enantioselective Keck allylation, ring-closing metathesis and Wittig olefination.  
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In 1977, Rúveda and coworkers reported the isolation of (R)-argentilactone (1) from Aristolochia 
argentia (Figure 1)1. Later, this natural pyranone was shown to have antileishmanial activity 
equivalent to the reference drug N-methylglucamine antimonate against Leishmania 
amazonensis2, as well as cytotoxic activity against mouse leukaemia cells (P-388)3. 
(R)-Goniothalamin (2) was isolated in 1967 from the dried bark of Cryptocarya caloneura 
(Figure 1)4. It is a potential cytotoxic compound that has been demonstrated to have 
antiproliferative activities in a number of transformed cell lines including MCF-7 (breast 
carcinoma) and HeLa cells (human cervical carcinoma)5,6. Recent studies have indicated that 
gonithalamin induced apoptosis in JurKat T-cells from activation of two members of the family 
of cysteine proteases, caspases-3 and -7. Deregulation of apoptosis has now been implicated in 
the onset or progression of cancer7. Consequently, apoptosis represents an innate cellular defense 
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against carcinogen-induced cellular damage by removing and inhibiting survival and growth of 







(R)-Goniothalamin (2)  
 
Figure 1. Structures of (R)-argentilactone (1) and (R)-goniothalamin (2). 
 
Due to the interesting biological activity displayed by (R)-argentilactone (1) and (R)-
goniothalamin (2), several successful aproaches to these natural products have been reported8. 
Both substances contain the 5,6-dihydro-2H-pyran-2-one  moiety and bear the (R)-configuration 
in their natural form. In this work, we describe the formal synthesis of (R)-argentilactone and the 
total synthesis of (R)-goniothalamin from benzyl alcohol featuring Lemieux-Johnson oxidative 
cleavage, enatioselective Keck allylation, ring-closing metathesis and Wittig reactions as the key 
steps (Scheme 1). 
 
 
Results and Discussion 
  
Our approach to these natural products centered around the olefin ring-closing metathesis 
reaction9 of 7 that was planned to be prepared in enantiomerically enriched form from allylic 
alcohol 6 available in good yield and enantiomeric excess from benzyloxyacetaldehyde (5) 
according to the catalytic asymmetric allylation protocol developed by Keck and coworkers10. 
Benzyloxyacetaldehyde (5) was obtained in 78% overall yield from benzyl alcohol by 
treatment with sodium hydride and allyl bromide, followed by oxidative cleavage according to 
the Lemieux-Johnson protocol11. In the event, reaction of benzyloxyacetaldehyde (5) with 
allyltributyltin, under the influence of chiral (R)-BINOL/Ti(OiPr)4 complex generated in situ in 
CH2Cl2 and in the presence of molecular sieves at –20 oC for 72 h afforded 6 in 78% yield and 
94% ee10. Enantiomeric excess was determined by chiral GC (column Chirasil-DEX CB) after 
conversion of the 6 to acrylate ester 7 (acrylolyl chloride, Et3N and catalytic amount of DMAP in 
CH2Cl2 at –23 oC, 86% yield). Ring-closing metathesis of 7 with Grubbs’ catalyst9 (10 mol%) in 
refluxing CH2Cl2 for 12 h furnished the corresponding α,β-unsaturated δ-lactone 8 in 69% yield 
from 6 (Scheme 1). 
At this point, our efforts were directed to the selective removal of the benzyl group in 8. 
While no reaction was observed with lithium naphthalenide12, lithium tert-butyldiphenyl 
(LiDBB)13 and tin(IV) chloride14, hydrogenolysis with Pd(OH)/C15 (1 atm of H2) promoted the 
reduction of the α,β-unsaturated bond. Low yield was obtained using titanium(IV) chloride16, 
chromium(II) chloride/lithium iodide17 and boron tribromide18. In our hands, utilization of ferric 
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chloride19 in CH2Cl2 at rt achieved debenzylation of  8 to give 9 in 88% yield. The preparation of  
(6R)-hydroxymethyl-5,6-dihydro-2H-pyran-2-one (9) in 6 steps and 42% overall yield, starting 
from benzyl alcohol, constitutes a formal synthesis of both (R)-argentilactone (1) and (R)-
goniothalamin (2) as Tsubuki and coworkers have previously described the total synthesis of 






(R)-(+)-Goniothalamin (2), R1 = H, R2 = Ph





























Conditions: a) NaH, KI, DMF, allyl bromide (98%); b) OsO4, Et2O/H2O, NaIO4 (80%); c) (R)-
BINOL (10 mol%), Ti(OiPr)4 (10 mol%), molecular sieves (4Å), allyltributyltin, -20 oC, 60 h 
(78%; 94% ee); d) acryloyl chloride,  Et3N, CH2Cl2, 0 oC (86%); e) Grubbs’ catalyst 
[(Pcy3)2Cl2Ru=CHPh], CH2Cl2 (91%); f) FeCl3, CH2Cl2 (88%); g) (COCl)2, CH2Cl2, DMSO, 




The efficient access to dihydropyranone 9 and our interest  in the biological evaluation of 
(R)-goniothalamin (2) and some of its congeners led us to explore the route described by Tsubuki 
and coworkers to (R)-goniothalamin (2)20. Wittig olefination of the corresponding aldehyde 
(prepared from 9 by Swern oxidation and employed in the next step without further purification) 
with a  solution of benzylidenetriphenylphosphorane (prepared by treatment of the corresponding 
triphenyl phosphonium chloride with n-BuLi in THF) afforded, after column chromatography on 
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silica gel, a 1:3 molar ratio (53% yield) of (R)-goniothalamin (2) (13% yield) and its 
corresponding Z-isomer 10 (40% yield). In Table 1 are presented the 1H-NMR and 13C-NMR 
data of natural4b and synthetic (R)-goniothalamin (2). 
 













H Natural4b Synthetic C Natural4b Synthetic 
 δ, multiplicity (J) δ, multiplicity (J)  δ δ 
3 6.09, dt (10, 2) 6.08, d (9.5) 2 163.9 163,6 
4 6.93, dt (10, 4) 6.92, dt (9.5, 4) 3 121.5 121,4 
5 2.54, m 2.56-2.52,  m 4 144.7 144,5 
6 5.10, qd (7, 1) 5.10, q (6.9) 5 29.8 29,8 
1´ 6.27, dd (16, 6) 6.27, dd (15.9, 6.2) 6 77.9 77,8 
2´ 6.73, d (16) 6.72, d (15.9) 1´ 125.6 125,5 
HAr 7.30, m 7.41-7.25, m 2´ 133.1 132,8 
   1” 135.7 135,5 
   2”/6” 126.6 126,5 
   3”/5” 128.6 128,5 
   4” 128.5 128,1 
a Chemical shifts are reported in δ [ppm relative to (CH3)4Si] for 1H and CDCl3 for 13C NMR. 
For 1H NMR, the chemical shifts were followed by multiplicity (s, singlet; d, doublet; dd, double 
dublet; ddd, double double dublet; t, triplet; q, quartet; m, multiplet) and coupling constant, J, 
reported in Hertz (Hz). 
 
The stereochemistry of the olefination products was assigned based on the coupling constants 
between the olefinic hydrogens H-1’ and H-2’ (15.9 Hz for the minor isomer and 11.3 Hz for  the 
major one) as well as by comparison of the 1H- and 13C-NMR data of the synthetic and natural4b 
(R)-goniothalamin (2). 
Despite the low level of diastereoselection found in the Wittig olefination, Tsubuki and 
coworkers20 have already shown that the yield of (R)-goniothalamin (2) could be enhanced by 
photochemical isomerization of (Z)-10 in the presence of diphenyldisulfide to afford a 2:1 ratio 
of (R)-goniothalamin (2) and (Z)-10 in 65% yield. Additionally, recent results by Enders and 
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coworkers8c and Kalesse and coworkers8f have demonstrated that the use o tributylphosphonium 
bromide and potassium tert-butoxide provides a better solution for the preparation of E isomer 
via Wittig olefination. 
With an expeditous enantioselective catalytic approach to (6R)-hydroxymethyl-5,6-dihydro-
2H-pyran-2-one ( 9) in hand, we are currently exploring the preparation of some (R)-
goniothalamin (2) and (R)-argentilactone (1) derivatives for biological evaluation. 
In this work, we have performed the formal synthesis of (R)-argentilactone (1) and the total 
synthesis of (R)-goniothalamin (2) which was obtained in 7 steps and 6% overall yield together 
with the correspondent (Z)-10 isomer (18%  overall yield). This approach illustrates the utility of 
the enantioselective catalytic allylation to provide rapid access to synthetically useful α,β-





General Procedures. Reagents and solvents are commercial grade and were used as supplied, 
with the following exceptions: a) ether and THF were destilled from sodium benzophenone 
ketyl; b) dichloromethane and triethylamine were distilled from calcium hydride and c) oxalyl 
chloride and dimethyl sulfoxide were distilled prior to use. Chromatographic separations were 
performed using 70-230 Mesh silica gel. Thin-layer chromatography was carried out on 
Macherey-Nagel precoated silica plates (0.25 mm layer thickness). IR spectra were obtained on 
Nicolet Impact 410 FT (film on KBr plates or KBr pellets). Melting points were measured with 
an Eletrothermal AZ9003 MK3 apparatus and are uncorrected. 1H NMR and 13C-NMR data were 
recorded on a Varian Gemini 300 (7.0 T) or Varian Inova (11.7 T) spectrometer. Chemical shifts 
are reported in δ [ppm relative to (CH3)4Si] for 1H and CDCl3 for 13C-NMR. For 1H-NMR, the 
chemical shifts were followed by multiplicity (s, singlet; d, doublet; dd, double dublet; ddd, 
double double dublet; t, triplet; q, quartet; m, multiplete) and coupling constant J reported in 
Hertz (Hz). High resolution mass spectra (HRMS) were measured on a VG Autospec-Micromass 
spectrometer.  Chiral GC analyses were performed with capillary column CP-Chirasil-DEX CB 
fused silica WCOT (25m x 0.25 mm x 0.25 µm) and chiral HPLC analyses were performed with 
Welk-O 2 column (25 cm x 10 mm i.d.). Optical rotations were measured at 25 oC with Perkin-
Elmer 241 instrument. 
  
Benzyloxyacetaldehyde (5). To a stirred solution of 1-(benzyloxy)-4-penten-2-ol21 (100 mg, 
0.683 mmol) in a mixture of  ether (2 mL) and water (2 mL) was added osmium tetroxide (3.6 
mg; 0.0013 mmol) and the mixture was stirred for 10 min at rt. Powdered sodium metaperiodate 
(318 mg, 1.51 mmol) was then added over a 25 min period and stirring was continued for 2 h at 
rt. The mixture was poured into water (20 mL) and extracted with ether (3 x 50 mL). The organic 
layer was dried with sodium sulfate and filtered. The solvent was removed in vacuo and the 
residual product was purified by column chromatography on silica gel using dichloromethane as 
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solvent to give known benzyloxyacetaldehyde (5, 92 mg, 80%): IR (film) 3032, 2862, 1736, 
1122, 744, 698 cm-1; 1H-NMR (500 MHz, CDCl3) δ 9.72 (t, 1H, J = 1.0 Hz), 7.39-7.27 (m, 5H), 
4.65 (s, 2H), 4.12 (d, 2H, J = 1,0 Hz); 13C-NMR (75 MHz, CDCl3) δ 200.1, 136.6, 128.3, 127.9, 
127.8, 75.1, 73.5. 
(R)-1-(Benzyloxy)-4-penten-2-ol (6)10. To a stirred solution of (R)-BINOL (75 mg, 0.26 mmol) 
in dichloromethane (2.6 mL) were added 4Å molecular sieves (powdered and activated by 
storing in an oven at 120 oC for several days), followed by 1.0 M dichloromethane soln. of 
titanium tetraisopropoxide (0.34 mL, 0.26 mmol) at rt. The orange-reddish suspension was 
heated at reflux for 1 h when the color of the reaction mixture changed to red-brown. The 
reaction mixture was cooled to rt and a soln. of benzyloxyacetaldehyde (5, 390 mg, 2.64 mmol) 
in dichloromethane (0.4 mL) was added. After 5  min stirring at rt, the mixture was cooled at –
78 oC and allyltributylstannane (0.98 mL, 3.12 mmol) was added. The resulting reaction was 
then kept in a freezer at –20 oC for 60 h without stirring when it was quenched with saturated 
aqueous NaHCO3 solution (20 mL) and diluted with dichloromethane (20 mL). This mixture was 
stirred at rt for 2 h and then filtered through a pad of Celite to remove the molecular sieves. The 
organic layer was separated and aqueous layer was extracted with dichloromethane (3 x 30 mL). 
The combined organic phases were dried over magnesium sulfate and evaporated under reduced 
pressure and the residual product purified by column chromatography [initially, hexane was used 
to elute recovered allyltributylstannane, then 4:2 hexane/acetone (v/v) was used as eluent to 
isolate the desired product] to give (R)-1-(benzyloxy)-4-penten-2-ol (6, 389 mg, 78%). The 
enantiomeric purity was determined to be 93% ee by CG analysis of the acryloyl ester derivative 
(column: CP-Chirasil-DEX CB, 25 m x 0.25 mm x 0.25 µm; conditions: initial 
temperature/initial time: 120 oC/30 min, final temperature/final time: 180 oC/50 min, rate: 
2 oC/min, H2 as the carrier gas and FID detector). IR (film) 3440, 3070, 2908, 2862,  1450, 1284, 
914, 741 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.40-7.20 (m, 5H), 5.88-5.74 (m, 1H), 5.14-5.06 
(m, 2H), 4.54 (s, 2H), 3.91-3.82 (m, 1H), 3.50 (dd, 1H, J = 9.5 and 3.5 Hz), 3.37 (dd, 1H, J = 9.5 
and 7.3 Hz), 2.45 (d, 1H, J = 3.3 Hz), 2.28-2.23 (m, 2H); 13C-NMR (125 MHz, CDCl3) δ 137.8, 
134.0, 128.3, 127.6, 127.5, 117.5, 73.8, 73.3, 69.6, 37.9; HRMS (EI) m/z calc. for C12H16O2 [M]+ 
192.11503. Found: 192.10938. [α]D25 = -2.2 (c 2.64, CHCl3) {lit.22: [α]D25 = -2.20 (c 2.64, 
CHCl3)}. 
(R)-1-(Benzyloxy)-4-penten-2-ol acryloyl ester (7).  To a stirred solution of (R)-1-(benzyloxy)-
4-penten-2-ol (6, 70 mg, 0.36 mmol) in dichloromethane (0.4 mL) was added acryloyl chlroride 
(53 µL, 0.65 mmol) and triethylamine (0.18 mL, 1.30 mmol) at 0 oC. After stirring for 30 min, 
the reaction was quenched with saturated aqueous NaHCO3 solution. The organic layer was 
separated and the aqueous layer was extracted with dichloromethane (2 x 20 mL). The combined 
organic layers were washed with brine, dried over magnesium sulfate, and evaporated under 
reduced pressure and the residual product was purified by column chromatography (5% 
dichloromethane in hexane, v/v) to give  acryloyl ester 7 (77 mg, 86%):  IR (film) 1724, 1635, 
1408, 1269 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.32-7.26 (m, 5H), 6.41 (dd, 1H, J = 17.2 and 
1.5 Hz), 6.11 (dd, 1H, J = 17.2 and 9.7 Hz), 5.83-5,67 (m, 2H), 5.20-5.03 (m, 3H), 4.53 (ABq, 
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2H, J = 12.0 Hz), 3.56 (d, 2H, J = 5.1 Hz), 2.49-2.37 (m, 2H); 13C-NMR (125 MHz, CDCl3) δ 
165.4, 137.8, 132.9, 130.6, 128.4, 128.2, 127.5, 127.4, 117.9, 73.1, 72.0, 70.4, 35,3; HRMS (EI) 
m/z calc. for C15H18O3 [M]+ 246.12560. Found: 246.12597. [α]D25 = -1.6 (c 1.27, CHCl3). 
(R)-6-(Benzyloxymethyl)-5,6-dihydro-2-pyranone (8). To a stirred solution  of 
bis(tricyclohexylphosphine)benzylidine ruthenium (IV) dichloride (Grubbs’ catalyst, 2 mg, 10 
mol%) in dichloromethane (0.6 mL) at 55-60 oC was added (R)-1-(benzyloxy)-4-penten-2-ol 
acryloyl ester (7, 60 mg, 0.24 mmol) dissolved in dichloromethane (24 mL). The resulting 
mixture was heated for 15 h. After this period, the mixture was cooled at rt and evaporated under 
reduced pressure. The residual product was purified by column chromatography (30% ethyl 
acetate in hexane, v/v) to give (R)-6-benzyloxymethyl-5,6-dihydro-2-pyrone (8, 53 mg, 91%): IR 
(film) 3032, 2912, 1728, 1246, 741, 689 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.42-7.15 (m, 5H), 
6.90 (ddd, 1H, J = 9.8, 5.9 and 2.5 Hz), 6.03 (ddd, 1H, J = 9.8, 2.6 and 1.0 Hz), 4.65-4.59 (m, 
3H), 3.70 (d, 2H, J = 4.8 Hz), 2.64-2.36 (m, 2H); 13C-NMR (125 MHz, CDCl3) δ 16.4, 144.7, 
137.4, 128.2, 127.6, 127.5, 120.9, 76.5, 73.5, 70.7, 26.1; HRMS (EI) m/z calc. for C13H14O3 [M]+ 
218.09430. Found: 218.08900. [α]D25 = +116.7 (c 1.3, CHCl3). 
(R)-6-Hydroxymethyl-5,6-dihydro-2-pyranone (9). To a stirred solution of (R)-6-
benzyloxymethyl-5,6-dihydro-2-pyranone (8, 227 mg, 1.04 mmol) in dichloromethane (0.6 mL) 
at rt under argon atmosphere, anhydrous FeCl3 (506 mg, 3.12 mmol) was added. After 5 min the 
reaction was quenched by addition of water (1 mL) and diluted with dichloromethane (10 mL). 
The organic layer was separated and the aqueous layer was extracted with dichloromethane (5 x 
20 mL). The combined organic layers were dried over magnesium sulfate, filtered and the 
solvent was removed under reduced pressure.  The crude product was purified by column 
chromatography (ethyl acetate) to give (R)-6-hydroxymethyl-5,6-dihydro-2-pyranone (9, 133 
mg, 88%): IR (film) 3402, 3070, 2924, 1712, 1388, 1084, 820 cm-1; 1H-NMR (500 MHz, CDCl3) 
δ  6.94 (ddd, 1H, J = 9.7, 6.2 and 2.2 Hz), 6.04 (dd, 1H, J = 9.5 and 2.6 Hz), 4.60-4.52 (m, 1H), 
3.90 (dd, 1H, J = 12.2 and 2.9 Hz), 3.77 (dd, 1H, J = 12.2 and 4.8 Hz), 2.68-2.56 (m, 1H), 2.37-
2.27 (m, 2H); 13C-NMR (125 MHz, CDCl3): δ 163.6, 145.1, 120.8, 78.3, 63.8, 25.3; HRMS (EI) 
m/z calc. for C6H8O3 [M]+ 128.04735. Found: 128.04472. [α]D25 = +175.3 (c 1.0, CHCl3) {lit.9, 
[α]D25 = +174.9 (c 0.92, CHCl3). 
(R)-goniothalamin (2) and (6R, 7Z)-6-styryl-5,6-dihydro-2-pyranone (10)20.  To a stirred 
solution of oxalyl chloride (50 µL, 0.59 mmol) in dichloromethane (0.5 mL) was added a 
solution of dimethyl sulfoxide (60 µL, 0.78 mmol) in dichloromethane (0.5 mL) at  –65 oC under 
argon atmosphere. After 15 min, the (R)-6-hydroxymethyl-5,6-dihydro-2-pyranone (9, 50 mg, 
0,39 mmol) was added and stirring was continued for 30 min. Triethylamine (0.27 mL, 1.95 
mmol) was added and the mixture was stirred for further 15 min at the same temperature. After 
this period, benzylidenetriphenylphosphorane [prepared from benzytriphenylphosphonium 
chloride (1.52 g, 3.90 mmol) and n-butylithium (1.55 M hexane solution, 2.42 mL, 3.70 mmol) 
in THF (15 mL)] was slowly added at 0 oC. The mixture was stirred for 30 min at –65 oC and 
then was added of brine (20 mL). The organic layer was separated and aqueous layer was 
extracted with dichloromethane (3 x 20 mL). The combined organic layers was dried over 
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anhydrous magnesium sulfate, filtered and the solvent was removed under reduced pressure. The 
residual product was purified by column chromatography (15% ethyl acetate in hexane, v/v, as 
eluent). The first fraction gave the (6R, 7Z)-6-styryl-5,6-dihydro-2-pyranone (10, 31 mg, 40%) 
and the second gave the (R)-goniothalamin (2, 10 mg, 13%). (6R, 7Z)-6-styryl-5,6-dihydro-2-
pyranone (10) : IR (film) 3024, 2924, 1720, 1246, 748, 694 cm-1; 1H-NMR (500 MHz, CDCl3): δ 
7.40-7.27 (m, 5H), 6.88 (ddd, 1H, J = 9.7, 5.5 and 3.3 Hz), 6.78 (d, 1H, J = 11.3 Hz), 6.06 (ddd, 
1H, J = 9.7, 3.3 and 2.0 Hz), 5.84 (dd, 1H, J = 11.3 and 9.1 Hz), 5.31 (ddd, 1H, J = 11.3 and 9.1 
Hz), 2.59-2.40 (m, 2H); 13C-NMR (125 MHz, CDCl3): δ 16.9, 144.5, 135.6, 134.8, 128.6, 128.5, 
127.9, 128.8, 121.6, 74.1, 29.7; HRMS (EI) m/z calc. for C13H12O2 [M]+ 200.08373. Found: 
200.07891. [α]D = - 302 (c 0.4, CHCl3), {lit.9, [α]D = - 310.2 (c 0.44, CHCl3)}. (R)-
goniothalamin (2):  mp 81-82 oC, {lit.4f, mp 85 oC}; IR (film): 3055, 3024, 2924, 1720, 1246, 
814, 698 cm-1; 1H-NMR (500 MHz, CDCl3): δ 7.41-7.25 (m, 5H), 6.92 (dt, 1H, J = 9.5 and 4.0 
Hz), 6.72 (d, 1H, J = 15.9 Hz), 6.27 (dd, 1H, J = 15.9 and 6.2 Hz), 6.08 (d, 1H, J = 9.5 Hz), 5.10 
(q, 1H, J = 6.9 Hz), 2.56-2.52 (m, 2H); 13C-NMR (125 MHz, CDCl3): δ 163,6; 144,5; 135,5; 
132,8; 128,5; 128,1; 126,5; 125,5; 121,4; 77,8; 29,8; HRMS (EI) m/z calc.. for C6H8O3 [M]+ 
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